DAPAFLOZIN GM2/1000

Dapaflozin GM 2/1000 is a triple-combination oral antidiabetic tablet specially formulated for effective management of Type 2 Diabetes Mellitus. It combines three clinically proven ingredients:

• Dapagliflozin (10 mg) – An SGLT2 inhibitor that reduces blood sugar by eliminating excess glucose via urine.

• Glimepiride (2 mg) – A sulfonylurea that promotes natural insulin secretion.

• Metformin (1000 mg) – A biguanide that decreases glucose production in the liver and improves insulin sensitivity.

This formulation offers enhanced glycemic control for diabetic patients who are not adequately managed with dual therapy or lower-dose regimens.

Key Benefits:

• Effective blood glucose control for Type 2 diabetes

• Helps reduce insulin resistance

• May support weight management and reduce cardiovascular risk

• Convenient once-daily dosage improves patient compliance

• Delays onset of diabetes-related complications